Viewing nowViban Tablet 160 mg (Valsartan)
Valsartan 160mg
Tablet · Prescription medication
Kwangdong Pharmaceuticals Co., Ltd.

MFDS item code 200809283 · Notified 2008.09.05 · Insurance code 641803950
Treatment of essential hypertension and heart failure; reduction in the risk of death after myocardial infarction
This medication is used to effectively control blood pressure in patients with essential hypertension. It also helps improve heart failure symptoms in patients with heart failure who are intolerant to ACE inhibitors, classified as NYHA class II to IV. Additionally, it is used to reduce the risk of mortality in clinically stable patients with left ventricular dysfunction or systolic dysfunction following myocardial infarction. In summary, this medication is effective for essential hypertension, heart failure, and decreasing mortality risk post-myocardial infarction, significantly contributing to the improvement of the patient's condition.
(Tablets) * 40, 80, 160 mg 1. Essential hypertension Take with water during a meal or between meals. It is recommended to take the medicine at the same time each day (e.g., in the morning), if possible. 1) Adults: The recommended dose is 80 mg of valsartan orally once daily, regardless of sex or race. The blood pressure-lowering effect develops gradually within 2 weeks and reaches its maximum after 4 weeks. For patients whose blood pressure is not adequately controlled, the dose may be increased to 160 mg daily or a diuretic may be coadministered. If additional blood pressure reduction is needed, the dose may be increased to a maximum of 320 mg daily. 2) Elderly patients (aged 75 years and older): Initiate treatment with 40 mg of this medicine once daily. 3) Patients with renal impairment: (1) Creatinine clearance 20 ∼ 50 mL/min: No dose adjustment is necessary. (2) Creatinine clearance 10 ∼ 20 mL/min: Initiate treatment with 40 mg of this medicine once daily. (3) Creatinine clearance below 10 mL/min and patients on dialysis: Do not administer this medicine. 4) Patients with volume depletion: In patients with volume depletion (e.g., patients taking high doses of diuretics whose dose cannot be reduced), initiate treatment with 40 mg of this medicine once daily. 5) Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, initiate treatment with 40 mg of this medicine once daily; do not exceed 80 mg daily. Do not administer this medicine to patients with severe hepatic impairment, cirrhosis, or cholestasis. 2. Heart failure Adults: The recommended starting dose is 40 mg of this medicine orally twice daily. The dose may be increased to 80 mg or 160 mg per dose. When administered concomitantly with a diuretic, consider reducing the diuretic dose. The maximum daily dose is 320 mg, administered in divided doses. Triple combination therapy with this medicine, an ACE inhibitor, and a beta-blocker is not recommended. 3. Reduction of the risk of death after myocardial infarction Adults: Treatment may be initiated within 12 hours of the onset of myocardial infarction. The recommended starting dose is 20 mg of this medicine twice daily. Thereafter, over several weeks, increase the dose as tolerated by the patient to 40 mg, 80 mg, and 160 mg per dose, administered twice daily. Consider dose reduction if symptoms of hypotension or renal failure occur. This medicine may also be administered to patients receiving other treatments after myocardial infarction (e.g., thrombolytic agents, acetylsalicylic acid, beta-blockers, and statins). However, concomitant use with an ACE inhibitor is not recommended. 4. Patients with renal impairment: No dose adjustment is necessary when creatinine clearance is 10 mL/min or higher. However, do not administer this medicine to patients with creatinine clearance below 10 mL/min or to patients on dialysis, as there is no experience with its use in these patients. 5. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, it is preferable not to exceed a daily dose of 80 mg. If administering 80 mg or more daily, consider whether the benefits of dose escalation outweigh the risks. Do not administer this medicine to patients with severe hepatic impairment, cirrhosis, or cholestasis.
The safety and efficacy of this medicine have not been established in children and adolescents under 18 years of age. The safety and efficacy of this medicine have not been established in children and adolescents under 18 years of age.
This medication may cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters, therefore it must be discontinued immediately upon confirmation of pregnancy. Women who are pregnant or may become pregnant and nursing mothers should not take this medication. Patients with severely impaired liver function, liver cirrhosis, or biliary obstruction should not take this medication. Patients with hereditary angioedema or a history of angioedema while on ACE inhibitors or angiotensin II receptor antagonists should avoid this medication. Patients with severe renal impairment, primary hyperaldosteronism, and those with certain renal disorders and diabetes should avoid this medication in combination with specific drugs. Elderly patients or those with hyperkalemia, and patients with mild liver impairment should be especially cautious when using this medication, as they may experience a rapid drop in blood pressure; therefore, starting with a low dose and gradually increasing it is recommended. Patients with heart failure or after myocardial infarction should pay attention to changes in renal function and hypotension and must undergo renal function tests before and during treatment. This medication can increase potassium levels in the blood, so caution is necessary when taken with potassium-sparing diuretics or potassium supplements, and frequent monitoring of potassium levels is advised. When co-administered with other antihypertensives, diuretics, or NSAIDs, the effectiveness may change, hence consultation with a physician or pharmacist is required. This medication may cause dizziness or drowsiness, so caution is needed while driving or operating machinery. If any unusual symptoms or allergic reactions occur during treatment, immediate consultation with medical personnel is necessary, especially if symptoms of angioedema such as swelling of the face, lips, or tongue occur, in which case, medication must be discontinued immediately. In case of overdose, hypotension or decreased consciousness may occur, requiring immediate emergency treatment. This medication must be kept out of reach of children, and transferring it to other containers is not advisable for quality maintenance.
headache
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. Additionally, it is important to store it in a cool place below 30 degrees Celsius to maintain its efficacy.
Oval film-coated tablet with an orange color tinged gray
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowValsartan 160mg
Tablet · Prescription medication
Kwangdong Pharmaceuticals Co., Ltd.

Valsartan 80mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

Valsartan 160mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

Valsartan 40mg
Tablet · Prescription medication
Samsung Novartis Co., Ltd.
Valsartan
Prescription medication
Korea Sandos Co., Ltd.
Valsartan
Prescription medication
Korea Sandos Co., Ltd.

Valsartan
Prescription medication
Korea Sandos Co., Ltd.

Valsartan 320mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.